# Loperamide

## Imolex 2mg

| TAH Drug Code      | [OIMO2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OIMO2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute and chronic diarrhea.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Adults: Diarrhea: 4 mg PO followed by 2 mg after each unformed stool; MAX 16 mg/day. Children: Acute Diarrhea: Use weight to dose. If weight not available, use age. 2-5 years (13-20 kg): 1 mg PO TID on day 1; followed by 1 mg/10 kg body weight after subsequent loose stools. MAX 3 mg/day. 6-8 years of age (22-27 kg): 2 mg PO after the first loose stool followed by 1 mg following each subsequent loose stool. MAX 4 mg/day. 9-11 years of age (27-43 kg): 2 mg PO after the first loose stool followed by 1 mg following each subsequent loose stool. MAX 6 mg/day. 12 to <13 years: 4 mg PO after the first loose stool followed by 2 mg following each subsequent loose stool. MAX 8 mg/day. >13 years: 4 mg PO followed by 2 mg after subsequent loose stools. MAX 16 mg/day. Chronic Diarrhea: 0.08-0.24 mg/kg/day PO in 2-3 divided doses. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | [仿單] Patients who have had an allergic reaction to any component of this medication. [Uptodate] Hypersensitivity to loperamide or any component of the formulation; abdominal pain without diarrhea; children <2 years; acute dysentery; acute ulcerative colitis; bacterial enterocolitis (caused by Salmonella, Shigella, and Campylobacter); pseudomembranous colitis associated with broad-spectrum antibiotic use. Canadian labeling: Additional contraindications (not in the US labeling): When constipation should be avoided; when the inhibition of peristalsis should be avoided.                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Abdominal pain (1.4%), Nausea (1.8%), Vomiting, Somnolence, Bloating, Constipation, Loss of appetite, Rash, Drowsiness or dizziness, Dry mouth. Serious: Necrotizing enterocolitis in fetus OR newborn.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/loperamide-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

